Beatrice S. Knudsen
No Rating Available
(Learn About Our Rating System)

Beatrice S. Knudsen, MD, PhD

  • Over the last 10 years, I built a program that integrates histopathology, multiplex tissue staining, digital image analysis and computational pathology for biomarker development. Advances in machine learning and high-performance computing permit the extraction of quantitative data from images of cancer tissues form patients and mouse models and to use images as molecular datasets. I am applying this approach to close the gap between laboratory research and clinical care and to develop novel algorithms for diagnosis, prognostication and treatment of cancer patients.

    Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Anatomic Pathology

  • Over the last 10 years, I built a program that integrates histopathology, multiplex tissue staining, digital image analysis and computational pathology for biomarker development. Advances in machine learning and high-performance computing permit the extraction of quantitative data from images of cancer tissues form patients and mouse models and to use images as molecular datasets. I am applying this approach to close the gap between laboratory research and clinical care and to develop novel algorithms for diagnosis, prognostication and treatment of cancer patients.

    Board Certification and Academic Information

    Academic Departments Pathology -Professor (Clinical)
    Board Certification
    American Board of Anatomic Pathology

    Selected Publications

    Journal Article

    1. Samson SC, Rojas A, Zitnay RG, Carney KR, Hettinga W, Schaelling MC, Sicard D, Zhang W, Gilbert-Ross M, Dy GK, Cavnar MJ, Furqan M, Browning RF Jr, Naqash AR, Schneider BP, Tarhini A, Tschumperlin DJ, Venosa A, Marcus AI, Emerson LL, Spike BT, Knudsen BS, Mendoza MC (2024). Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK. bioRxiv. (Read full article)
    2. Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Di Vizio D, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR (2024). ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res, 52(13), 7740-7760. (Read full article)
    3. Knudsen BS, Jadhav A, Perry LJ, Thagaard J, Deftereos G, Ying J, Brintz BJ, Zhang W (2024). A Pipeline for Evaluation of Machine Learning/Artificial Intelligence Models to Quantify Programmed Death Ligand 1 Immunohistochemistry. Lab Invest, 104(6), 102070. (Read full article)
    4. Zamora I, Gutirrez M, Pascual A, Pajares MJ, Barajas M, Perez LM, You S, Knudsen BS, Freeman MR, Enco IJ, Rotinen M (2024). ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity. Cell Oncol (Dordr). (Read full article)
    5. Ferrero A, Ghelichkhan E, Manoochehri H, Ho MM, Albertson DJ, Brintz BJ, Tasdizen T, Whitaker RT, Knudsen BS (2024). HistoEM: A Pathologist-Guided and Explainable Workflow Using Histogram Embedding for Gland Classification. Mod Pathol, 37(4), 100447. (Read full article)
    6. Wadhwa A, Roscoe C, Duran EA, Kwan L, Haroldsen CL, Shelton JB, Cullen J, Knudsen BS, Rettig MB, Pyarajan S, Nickols NG, Maxwell KN, Yamoah K, Rose BS, Rebbeck TR, Iyer HS, Garraway IP (2024). Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems. JAMA Netw Open, 7(3), e242852. (Read full article)
    7. Marr KD, Gard JMC, Harryman WL, Keeswood EJ, Paxson AI, Wolgemuth C, Knudsen BS, Nagle RB, Hazlehurst L, Sorbellini M, Cress AE (2023). Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo. Biophys J, 122(21), 4194-4206. (Read full article)
    8. Ng AHC, Hu H, Wang K, Scherler K, Warren SE, Zollinger DR, McKay-Fleisch J, Sorg K, Beechem JM, Ragaglia E, Lacy JM, Smith KD, Marshall DA, Bundesmann MM, Lpez de Castilla D, Corwin D, Yarid N, Knudsen BS, Lu Y, Goldman JD, Heath JR (2023). Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2. Cell Rep, 42(10), 113212. (Read full article)
    9. Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Vizio DD, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR (2023). ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer. (Read full article)
    10. Kataria T, Rajamani S, Ayubi AB, Bronner M, Jedrzkiewicz J, Knudsen BS, Elhabian SY (2023). Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry. Mod Pathol, 36(12), 100331. (Read full article)
    11. Zhang W, Koh MY, Sirohi D, Ying J, Brintz BJ, Knudsen BS (2023). Predicting IHC staining classes of NF1 using features in the hematoxylin channel. J Pathol Inform, 14, 100196. (Read full article)
    12. Liu Y, Wang J, Horton C, Yu C, Knudsen B, Stefanson J, Hu K, Stefanson O, Green J, Guo C, Xie Q, Wang ZA (2021). Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cells. Cell Rep, 39(8), 110848. (Read full article)
    13. Kane N, Romero T, Diaz-Perez S, Rettig MB, Steinberg ML, Kishan AU, Schaue D, Reiter RE, Knudsen BS, Nickols NG (2022). Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. Prostate Cancer Prostatic Dis. (Read full article)
    14. Pollan SG, Teng PC, Jan YJ, Livingstone J, Huang C, Kim M, Mariscal J, Rodriguez M, Chen JF, You S, DiVizio D, Boutros PC, Chan KS, Rasorenova O, Cress A, Spassov D, Moasser M, Posadas EM, Freedland SJ, Freeman MR, Zheng JJ, Knudsen BS (2021). Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. Am J Clin Exp Urol, 9(4), 350-366. (Read full article)
    15. Parikh NR, Kishan AU, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, Felix C, Mathis C, Bradley M, Sachdeva A, Wyatt B, Basehart V, Zomorodian N, Lin L, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Elashoff D, Schaue D, Reiter RE, Nickols NG (2020). Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys, 108(4), 930-935. (Read full article)
    16. Zhang W, Rhodes JS, Moon KR, Knudsen BS, Nokolova L, Zhou A (2020). Imaging of PD-L1 in single cancer cells by SERS-based hyperspectral analysis. Biomed Opt Express, 11(11), 6197-6210. (Read full article)
    17. Kouspou MM, Fong JE, Brew N, Hsiao STF, Davidson SL, Choyke PL, Crispino T, Jain S, Jenster GW, Knudsen BS, Millar JL, Mittmann N, Ryan CJ, Tombal B, Buzza M (2020). The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs. Nat Rev Urol, 17(9), 499-512. (Read full article)
    18. Huang F, Tanaka H, Knudsen BS, Rutgers JK (2020). Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain. BMC Med Genet, 21(1), 167. (Read full article)
    19. Fassler DJ, Abousamra S, Gupta R, Chen C, Zhao M, Paredes D, Batool SA, Knudsen BS, Escobar-Hoyos L, Shroyer KR, Samaras D, Kurc T, Saltz J (2020). Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images. Diagn Pathol, 15(1), 100. (Read full article)
    20. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D (2020). The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. Prostate Cancer Prostatic Dis, 24, 135-139. (Read full article)
    21. Miller ET, You S, Cadaneanu RM, Kim M, Yoon J, Liu ST, Li X, Kwan L, Hodge J, Quist MJ, Grasso CS, Lewis MS, Knudsen BS, Freeman MR, Garraway IP (2020). Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential. BMC Cancer, 20(1), 398. (Read full article)
    22. Wang M, Nagle RB, Knudsen BS, Cress AE, Rogers GC (2019). Centrosome loss results in an unstable genome and malignant prostate tumors. Oncogene, 39(2), 399-413. (Read full article)
    23. Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, Kuras M, Oskolas H, Kim Y, Horvath Z, Eriksson J, Berge E, Burestedt E, Jnsson G, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Horvatovich P, Murillo JR, Sugihara Y, Welinder C, Wieslander E, Lee B, Lindberg H, Pawowski K, Kwon HJ, Doma V, Timar J, Karpati S, Szasz AM, Nmeth IB, Nishimura T, Corthals G, Rezeli M, Knudsen B, Malm J, Marko-Varga G (2019). Clinical protein science in translational medicine targeting malignant melanoma. Cell Biol Toxicol, 35(4), 293-332. (Read full article)
    24. Jan YJ, Yoon J, Chen JF, Teng PC, Yao N, Cheng S, Lozano A, Chu GCY, Chung H, Lu YT, Chen PJ, Wang JJ, Lee YT, Kim M, Zhu Y, Knudsen BS, Feng FY, Garraway IP, Gao AC, Chung LWK, Freeman MR, You S, Tseng HR, Posadas EM (2019). A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. Theranostics, 9(10), 2812-2826. (Read full article)
    25. Li W, Li J, Sarma KV, Ho KC, Shen S, Knudsen BS, Gertych A, Arnold CW (2018). Path R-CNN for Prostate Cancer Diagnosis and Gleason Grading of Histological Images. IEEE Trans Med Imaging, 38(4), 945-954. (Read full article)
    26. Wang M, Knudsen BS, Nagle RB, Rogers GC, Cress AE (2019). A method of quantifying centrosomes at the single-cell level in human normal and cancer tissue. Mol Biol Cell, 30(7), 811-819. (Read full article)
    27. Wang M, Hinton JP, Gard JMC, Garcia JGN, Knudsen BS, Nagle RB, Cress AE (2019). Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell-cell and cell-extracellular matrix interactions. Mol Biol Cell, 30(7), 838-850. (Read full article)
    28. Guedes LB, Morais CL, Fedor H, Hicks J, Gurel B, Melamed J, Lee P, Gopalan A, Knudsen BS, True LD, Scher HI, Fine SW, Trock BJ, De Marzo AM, Lotan TL (2018). Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer. Arch Pathol Lab Med, 143(3), 338-348. (Read full article)
    29. Gertych A, Swiderska-Chadaj Z, Ma Z, Ing N, Markiewicz T, Cierniak S, Salemi H, Guzman S, Walts AE, Knudsen BS (2019). Convolutional neural networks can accurately distinguish four histologic growth patterns of lung adenocarcinoma in digital slides. Sci Rep, 9(1), 1483. (Read full article)
    30. Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE (2018). PARP-1 regulates DNA repair factor availability. EMBO Mol Med, 10(12). (Read full article)
    31. Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yez A, Hazelett DJ, Chu CY, Steadman K, Morrissey CM, Nelson PS, Corey E, Chung LWK, Freedland SJ, Di Vizio D, Garraway IP, Murali R, Knudsen BS, Freeman MR (2018). ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med, 24(12), 1887-1898. (Read full article)
    32. Reis-Sobreiro M, Chen JF, Novitskaya T, You S, Morley S, Steadman K, Gill NK, Eskaros A, Rotinen M, Chu CY, Chung LWK, Tanaka H, Yang W, Knudsen BS, Tseng HR, Rowat AC, Posadas EM, Zijlstra A, Di Vizio D, Freeman MR (2018). Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential. Cancer Res, 78(21), 6086-6097. (Read full article)
    33. Li J, Speier W, Ho KC, Sarma KV, Gertych A, Knudsen BS, Arnold CW (2018). An EM-based semi-supervised deep learning approach for semantic segmentation of histopathological images from radical prostatectomies. Comput Med Imaging Graph, 69, 125-133. (Read full article)
    34. Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE (2018). Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Mol Cancer Res, 16(8), 1319-1331. (Read full article)
    35. Padilla-Rodriguez M, Parker SS, Adams DG, Westerling T, Puleo JI, Watson AW, Hill SM, Noon M, Gaudin R, Aaron J, Tong D, Roe DJ, Knudsen B, Mouneimne G (2018). The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion. Nat Commun, 9(1), 2980. (Read full article)
    36. Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Dela Cruz FS, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A (2018). A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat Genet, 50(7), 979-989. (Read full article)
    37. Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, Knudsen BS (2018). Regulation of inside-out β1-integrin activation by CDCP1. Oncogene, 37(21), 2817-2836. (Read full article)
    38. Li J, Sarma KV, Chung Ho K, Gertych A, Knudsen BS, Arnold CW (2018). A Multi-scale U-Net for Semantic Segmentation of Histological Images from Radical Prostatectomies. AMIA Annu Symp Proc, 2017, 1140-1148. (Read full article)
    39. Hu J, Schokrpur S, Archang M, Hermann K, Sharrow AC, Khanna P, Novak J, Signoretti S, Bhatt RS, Knudsen BS, Xu H, Wu L (2018). A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Mol Ther Methods Clin Dev, 9, 203-210. (Read full article)
    40. Ing N, Huang F, Conley A, You S, Ma Z, Klimov S, Ohe C, Yuan X, Amin MB, Figlin R, Gertych A, Knudsen BS (2017). A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome. Sci Rep, 7(1), 13190. (Read full article)
    41. Ma Z, Shiao SL, Yoshida EJ, Swartwood S, Huang F, Doche ME, Chung AP, Knudsen BS, Gertych A (2017). Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate. Diagn Pathol, 12(1), 69. (Read full article)
    42. Allott EH, Macias E, Sanders S, Knudsen BS, Thomas GV, Hursting SD, Freedland SJ (2017). Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model. Prostate Cancer Prostatic Dis, 20(2), 165-171. (Read full article)
    43. Das L, Anderson TA, Gard JM, Sroka IC, Strautman SR, Nagle RB, Morrissey C, Knudsen BS, Cress AE (2017). Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells. J Cell Biochem, 118(5), 1038-1049. (Read full article)
    44. Conley A, Minciacchi VR, Lee DH, Knudsen BS, Karlan BY, Citrigno L, Viglietto G, Tewari M, Freeman MR, Demichelis F, Di Vizio D (2016). High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients. RNA Biol, 14(3), 305-316. (Read full article)
    45. Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE (2016). A basal cell defect promotes budding of prostatic intraepithelial neoplasia. J Cell Sci, 130(1), 104-110. (Read full article)
    46. Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP (2016). Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med, 6(1), 163-172. (Read full article)
    47. Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE (2016). The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta, 1866(2), 221-231. (Read full article)
    48. Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP (2016). Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone. PLoS One, 11(10), e0163232. (Read full article)
    49. You S, Knudsen BS, Erho N, Alshalalfa M, Takhar M, Al-Deen Ashab H, Davicioni E, Karnes RJ, Klein EA, Den RB, Ross AE, Schaeffer EM, Garraway IP, Kim J, Freeman MR (2016). Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Res, 76(17), 4948-58. (Read full article)
    50. Vidal AC, Chen Z, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Taioli E, Fowke JH, Knudsen B, Drake CG, Nickel JC, Freedland SJ (2016). Racial differences in prostate inflammation: results from the REDUCE study. Oncotarget, 8(42), 71393-71399. (Read full article)
    51. Pham H, Hui H, Morvaridi S, Cai J, Zhang S, Tan J, Wu V, Levin N, Knudsen B, Goddard WA 3rd, Pandol SJ, Abrol R (2016). A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells. Biochem Biophys Res Commun, 475(3), 295-300. (Read full article)
    52. Huang F, Ma Z, Pollan S, Yuan X, Swartwood S, Gertych A, Rodriguez M, Mallick J, Bhele S, Guindi M, Dhall D, Walts AE, Bose S, de Peralta Venturina M, Marchevsky AM, Luthringer DJ, Feller SM, Berman B, Freeman MR, Alvord WG, Vande Woude G, Amin MB, Knudsen BS (2016). Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. J Pathol Clin Res, 2(4), 210-222. (Read full article)
    53. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP (2016). Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn, 18(3), 395-406. (Read full article)
    54. Edderkaoui M, Xu S, Chheda C, Morvaridi S, Hu RW, Grippo PJ, Mascarias E, Principe DR, Knudsen B, Xue J, Habtezion A, Uyeminami D, Pinkerton KE, Pandol SJ (2015). HDAC3 mediates smoking-induced pancreatic cancer. Oncotarget, 7(7), 7747-60. (Read full article)
    55. Gertych A, Ma Z, Tajbakhsh J, Velsquez-Vacca A, Knudsen BS (2015). Rapid 3-D delineation of cell nuclei for high-content screening platforms. Comput Biol Med, 69, 328-38. (Read full article)
    56. Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, Gallick GE, Mallick J, Ryan C, Galsky MD, Lerner SP, Posadas EM, Sonpavde G (2015). Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. Urol Oncol, 34(1), 4.e11-7. (Read full article)
    57. Gertych A, Ing N, Ma Z, Fuchs TJ, Salman S, Mohanty S, Bhele S, Velsquez-Vacca A, Amin MB, Knudsen BS (2015). Machine learning approaches to analyze histological images of tissues from radical prostatectomies. Comput Med Imaging Graph, 46 Pt 2, 197-208. (Read full article)
    58. Ogden A, Rida PC, Knudsen BS, Kucuk O, Aneja R (2015). Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer Lett, 367(2), 89-92. (Read full article)
    59. Lai JP, Conley A, Knudsen BS, Guindi M (2015). Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. Histopathology, 67(4), 442-50. (Read full article)
    60. Morley S, You S, Pollan S, Choi J, Zhou B, Hager MH, Steadman K, Spinelli C, Rajendran K, Gertych A, Kim J, Adam RM, Yang W, Krishnan R, Knudsen BS, Di Vizio D, Freeman MR (2015). Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes. Sci Rep, 5, 12136. (Read full article)
    61. Qin Y, Walts AE, Knudsen BS, Gertych A (2014). Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers. Cytometry B Clin Cytom, 88(2), 110-9. (Read full article)

    Editorial

    1. Delahunt B, Hammond E, Egevad L, Samaratunga H, Srigley JR, Humphrey PA, Rubin M, Epstein JI, Lin DW, Gore JL, Nacey JN, Klotz L, Sandler H, Zietman AL, Holden S, Montironi R, Evans AJ, McKenney JK, Berney D, Wheeler TM, Chinnaiyan AM, True L, Knudsen B, Amin MB (2014). Active surveillance for prostate cancer: the role of the pathologist. Pathology, 47(1), 1-3. (Read full article)

    Other

    1. Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, Raps E, Haaland B, Sayegh N, Li H, Rathi N, Sharma P, Agarwal N, Knudsen B (2022). Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups. Clin Genitourin Cancer (20(3), pp. e233-e243). United States. (Read full article)
    2. Ouellet V, Erickson A, GAP1 UTMAs Contributing Investigators, Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AM, Garraway IP, Trock BJ, Taimen P, Saad F, Mirtti T, Knudsen BS, De Marzo AM (2021). The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer Epidemiol Biomarkers Prev (31(4), pp. 715-727). United States. (Read full article)
    3. Yan Y, Zhou B, Qian C, Vasquez A, Kamra M, Chatterjee A, Lee YJ, Yuan X, Ellis L, Di Vizio D, Posadas EM, Kyprianou N, Knudsen BS, Shah K, Murali R, Gertych A, You S, Freeman MR, Yang W (2022). Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis. Nat Commun (13(1), p. 669). England. (Read full article)
    4. Betancourt LH, Gil J, Sanchez A, Doma V, Kuras M, Murillo JR, Velasquez E, akr U, Kim Y, Sugihara Y, Parada IP, Szeitz B, Appelqvist R, Wieslander E, Welinder C, de Almeida NP, Woldmar N, Marko-Varga M, Eriksson J, Pawowski K, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Lindberg H, Oskolas H, Lee B, Berge E, Sjgren M, Eriksson C, Kim D, Kwon HJ, Knudsen B, Rezeli M, Malm J, Hong R, Horvath P, Szsz AM, Tmr J, Krpti S, Horvatovich P, Miliotis T, Nishimura T, Kato H, Steinfelder E, Oppermann M, Miller K, Florindi F, Zhou Q, Domont GB, Pizzatti L, Nogueira FCS, Szadai L, Nmeth IB, Ekedahl H, Feny D, Marko-Varga G (2021). The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome. Clin Transl Med (11(7), pp. e451). United States. (Read full article)
    5. Betancourt LH, Gil J, Kim Y, Doma V, akr U, Sanchez A, Murillo JR, Kuras M, Parada IP, Sugihara Y, Appelqvist R, Wieslander E, Welinder C, Velasquez E, de Almeida NP, Woldmar N, Marko-Varga M, Pawowski K, Eriksson J, Szeitz B, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Lindberg H, Oskolas H, Lee B, Berge E, Sjgren M, Eriksson C, Kim D, Kwon HJ, Knudsen B, Rezeli M, Hong R, Horvatovich P, Miliotis T, Nishimura T, Kato H, Steinfelder E, Oppermann M, Miller K, Florindi F, Zhou Q, Domont GB, Pizzatti L, Nogueira FCS, Horvath P, Szadai L, Tmr J, Krpti S, Szsz AM, Malm J, Feny D, Ekedahl H, Nmeth IB, Marko-Varga G (2021). The human melanoma proteome atlas-Defining the molecular pathology. Clin Transl Med (11(7), pp. e473). United States. (Read full article)
    6. Fassler DJ, Abousamra S, Gupta R, Chen C, Zhao M, Paredes D, Batool SA, Knudsen BS, Escobar-Hoyos L, Shroyer KR, Samaras D, Kurc T, Saltz J (2020). Publisher Correction to: Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images. Diagn Pathol (15(1), p. 116). England. (Read full article)
    7. Saylor J, Ma Z, Goodridge HS, Huang F, Cress AE, Pandol SJ, Shiao SL, Vidal AC, Wu L, Nickols NG, Gertych A, Knudsen BS (2018). Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining. Front Immunol (9, p. 2925). Switzerland. (Read full article)

    Patent

    1. Cao B, Boliang, Vande Woude GF, Knudsen BS (2011). Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods. U.S. Patent No. 7,892,770. Washington, D.C.:U.S. Patent and Trademark Office.

    Research Lab

    Lab link